Navigation Links
Move Cautiously in Approving New Obesity Drugs, Pulmonary Hypertension Association Says
Date:6/24/2013

Silver Spring, MD (PRWEB) June 24, 2013

The American Medical Association’s decision* to regard obesity as a disease is making top headlines this week, but in fact this is not the first time American health care has taken this view, according to the Pulmonary Hypertension Association (PHA). “In the 1990s, the results for too many who took prescription treatments for obesity were disastrous, resulting in a 6-fold increase in the incidence of life-threatening pulmonary hypertension,” said PHA president Rino Aldrighetti.

Two prescription weight loss drugs – fenfluramine and dexfenfluramine (also known as Redux, Pondimin and Fen-Phen) – were pulled from the market in 1997 after they were found to be associated with heart-valve problems. These drugs also resulted in increased incidence of pulmonary hypertension, or high blood pressure in the blood vessels between the heart and lungs. In cases of PH, these vessels narrow and stiffen, requiring the heart to work too hard to pump enough oxygenated blood to the body. Patients experience shortness of breath, chest pain, fainting, fatigue, and swelling of the legs and ankles. PH can make even daily activities such as walking difficult and limits thousands of patients’ ability to work, care for their homes and families and enjoy leisure activities.

Research published in 2002 showed that patients who took fenfluramine and dexfenfluramine developed PH after taking the drug for as little as 23 days. Those on the drug more than 3 months faced a 23-fold greater risk.

“This disease caused tremendous suffering and many premature deaths which might have been prevented if the effects of these drugs had been more carefully researched and disclosed. It’s essential that we avoid making this mistake again,” Aldrighetti said. “The last ‘war on obesity’ was driven by a combination of worthy concern and marketing emphasizing profit more than health. Many patients paid the price. That story is well told by journalist Alicia Mundy who coined the term ‘Obesity Inc.’ in her book about the legal battle over Fen-Phen, Dispensing with the Truth.

“Obesity is indeed a major public health concern,” Aldrighetti said, “but we need to remember our history and temper our well-founded concern about obesity with good judgment about the overall safety of new drugs to help Americans lose weight.”

PHA recommends that all patients speak with their physicians before considering using weight loss supplements and medications. PHA also recommends that patients with PH consult with their PH specialists about the possibility of using these products.

The mission of the Pulmonary Hypertension Association is to find ways to prevent and cure pulmonary hypertension, and to provide hope for the pulmonary hypertension community through support, education, research, advocacy and awareness. To learn more about pulmonary hypertension and its effects, visit http://www.PHAssociation.org.

*http://www.ama-assn.org/ama/pub/news/news/2013/2013-06-18-new-ama-policies-annual-meeting.page 6/18/2013 American Medical Association

Read the full story at http://www.prweb.com/releases/2013/6/prweb10863990.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Disrupted Sleep May Raise Risk for Obesity, Diabetes: Study
2. Obesitys Health Costs Double Earlier Estimates
3. Troubled Homes May Fuel Obesity in Girls
4. Childhood Obesity May Raise Odds of Adult Liver Cancer
5. Could the Childhood Obesity Epidemic Be Ebbing?
6. New research finds no association between white potato consumption (baked, boiled mashed) and obesity, Type 2 diabetes or systemic inflammation
7. Mayo Clinic: Obesity epidemic fueling rise in rheumatoid arthritis among women
8. Treating childhood obesity: A family affair
9. Rising Obesity Rates Might Mean More Rheumatoid Arthritis
10. Research May Point to New Obesity Treatments
11. U.S. Obesity Rate Set to Soar, Costing Billions: CDC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Women's ... , Roberta Jordan is a Certified Nurse Midwife who was born and raised ... then went on to complete her masters degree from the University of Mexico. ...
(Date:5/24/2016)... ... 24, 2016 , ... Educational opportunities, and therefore life chances, ... communities providing richer opportunities. Recognizing the key role of housing in this system, ... school choice policies; (c) school desegregation policies; (d) wealth-focused policies; and (e) housing-focused ...
(Date:5/24/2016)... ... 24, 2016 , ... Regenerative Medicine is being transformed by ongoing research and ... protocols and patient results as have been achieved with Okyanos Cell Therapy ... of care for patients worldwide. , As the Medical Advisory Chairman at Okyanos, Eric ...
(Date:5/24/2016)... ... 2016 , ... Backed by decades of experience, Metroloji Okulu ... the best suited solution to meet regulatory requirements. Their professional staff also performs ... Istanbul. , Metroloji Okulu specializes in MadgeTech’s line of medical and pharmaceutical ...
(Date:5/24/2016)... ... May 24, 2016 , ... American Gene Technologies ... to its board of directors. Otterstatter is co-founder, president and CEO of ... technological innovations that lead to broad-based healthcare solutions. , “Jon knows how to ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... LAWRENCE, Mass. , May 24, 2016  NxStage ... medical technology company focused on advancing renal care, today ... Officer, plans to participate in the following schedule of ... will be made available at http://ir.nxstage.com/ . ... Jefferies Healthcare Conference NY, NY           Friday, ...
(Date:5/24/2016)... , May 24, 2016 ... de doble terapia del mundo, introduce catéteres para ... OrbusNeich, una compañía global especializada en ... vidas, ha expandido su cartera incluyendo productos para ... JADE™ y Scoreflex™ PTA son los dispositivos de ...
Breaking Medicine Technology: